MENU
MENUVolume : IX, Issue : VIII, August - 2020
IVERMECTIN AS ADJUVANT TO HYDROXYCHOLOROQUINE IN PA-TIENTS RESISTANT TO STANDARD TREATMENT FOR SARS-CoV-2: RE-SULTS OF AN OPEN-LABEL RANDOMIZED CLINICAL STUDY
Dr. Naveen Kishoria, Dr. S. L Mathur, Dr. Veeram Parmar, Dr. Rimple Jeet Kaur, Dr. Harish Agarwal, Dr. B. S Parihar, Dr Somil Verma
Abstract :
Keywords :
Urothelial carcinoma Squamous cell carcinoma Papilloma Cystoscopic Bladder Biopsy Transurethral Resection of the bladder Tumour (TURBT)
Article:
Download PDF
DOI : https://www.doi.org/10.36106/paripex/4801859
Cite This Article:
IVERMECTIN AS ADJUVANT TO HYDROXYCHOLOROQUINE IN PA-TIENTS RESISTANT TO STANDARD TREATMENT FOR SARS-COV-2: RE-SULTS OF AN OPEN-LABEL RANDOMIZED CLINICAL STUDY, Dr. Naveen Kishoria, Dr. S.L Mathur, Dr. Veeram Parmar, Dr. Rimple Jeet Kaur, Dr. Harish Agarwal, Dr. B.S Parihar, Dr Somil Verma PARIPEX-INDIAN JOURNAL OF RESEARCH : Volume-9 | Issue-8 | August-2020
Number of Downloads : 181
References :
IVERMECTIN AS ADJUVANT TO HYDROXYCHOLOROQUINE IN PA-TIENTS RESISTANT TO STANDARD TREATMENT FOR SARS-COV-2: RE-SULTS OF AN OPEN-LABEL RANDOMIZED CLINICAL STUDY, Dr. Naveen Kishoria, Dr. S.L Mathur, Dr. Veeram Parmar, Dr. Rimple Jeet Kaur, Dr. Harish Agarwal, Dr. B.S Parihar, Dr Somil Verma PARIPEX-INDIAN JOURNAL OF RESEARCH : Volume-9 | Issue-8 | August-2020
